2025
SJR Q1
JCR Q2 · 4
17 eşleşen makale
SCIE
Dergi ayrıntısı
Expert Opinion on Biological Therapy
- Yayıncı
- Taylor and Francis Ltd.
- Ülke
- United Kingdom · Western Europe
- Tür
- journal
- ISSN
-
1471259817447682
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 1,045
- Quartile Q1
- H-Index 112
- Atıf/yayın 3,31
- Doküman (3y) 401
- Atıf (3y) 1.403
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 4
- 5Y JIF 4,1
- JCI 0,52
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Clinical Biochemistry Q1
- Drug Discovery Q1
- Pharmacology Q1
Alanlar
- Biochemistry, Genetics and Molecular Biology
- Pharmacology, Toxicology and Pharmaceutics
WoS kategorileri
- Biotechnology & Applied Microbiology | Medicine, Research & Experimental
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 1,045 | 4 | 4,1 | 0,52 | Q3 | 112 |
| 2024 | Q1 | Q2 | 1,15 | 4 | 4 | 0,59 | Q3 | 107 |
| 2023 | Q1 | Q2 | 1,104 | 3,6 | 4,2 | 0,61 | Q3 | 107 |
| 2022 | Q1 | Q2 | 1,12 | 4,6 | 4,1 | 0,63 | Q3 | 107 |
| 2021 | Q1 | Q1 | 1,001 | 5,6 | 4,5 | 0,65 | Q2 | 107 |
| 2020 | Q1 | Q2 | 1,088 | 4,4 | 4,2 | 0,71 | Q2 | 107 |
| 2019 | Q1 | Q2 | 0,917 | 3,2 | 3,1 | 0,71 | Q2 | 107 |
| 2018 | — | Q2 | — | 3,6 | 3,3 | 0,81 | Q2 | — |
| 2017 | Q1 | Q1 | 1,117 | 4 | 3,3 | 0,78 | Q2 | 107 |
| 2016 | Q1 | Q1 | 1,167 | 3,7 | 3,3 | — | — | 107 |
| 2015 | Q1 | Q1 | 1,18 | 3,4 | 3,1 | — | — | 107 |
| 2014 | Q1 | Q1 | 1,326 | 3,7 | 3,2 | — | — | 107 |
| 2013 | Q1 | Q1 | 1,288 | 3,7 | 3,1 | — | — | 107 |
| 2012 | Q1 | Q1 | 1,247 | 3,3 | 2,9 | — | — | 107 |
| 2011 | Q1 | Q1 | 1,312 | 3,5 | 2,9 | — | — | 107 |
| 2010 | Q1 | Q2 | 1,256 | 3,3 | 2,8 | — | — | 107 |
| 2009 | — | Q1 | — | 3,2 | 2,7 | — | — | — |
| 2008 | — | Q1 | — | 3,5 | 2,8 | — | — | — |
| 2007 | — | Q2 | — | 2,8 | 2,6 | — | — | — |
| 2006 | — | Q2 | — | 2,7 | — | — | — | — |
| 2005 | — | Q2 | — | 2,6 | — | — | — | — |
| 2004 | — | Q1 | — | 2,4 | — | — | — | — |
| 2003 | — | Q1 | — | 2,8 | — | — | — | — |
| 2002 | — | Q2 | — | 2 | — | — | — | — |
| 2001 | — | — | — | — | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | Q3 | 71/180 |
| 2025 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q3 | 70/191 |
| 2024 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | Q3 | 50/177 |
| 2024 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q3 | 62/195 |
| 2023 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | Q3 | 59/174 |
| 2023 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q3 | 72/189 |
| 2022 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | Q3 | 43/158 |
| 2022 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q3 | 58/136 |
| 2021 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | Q2 | 36/159 |
| 2021 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q3 | 48/139 |
| 2020 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | Q2 | 47/159 |
| 2020 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 64/140 |
| 2019 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | Q2 | 59/156 |
| 2019 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 67/139 |
| 2018 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | Q2 | 44/162 |
| 2018 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 51/136 |
| 2017 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | Q2 | 31/161 |
| 2017 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 34/133 |
| 2016 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 37/160 |
| 2016 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 32/128 |
| 2015 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 40/161 |
| 2015 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 33/124 |
| 2014 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 30/163 |
| 2014 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 28/123 |
| 2013 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 35/165 |
| 2013 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 28/124 |
| 2012 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 38/160 |
| 2012 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 39/121 |
| 2011 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 36/158 |
| 2011 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 31/112 |
| 2010 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 42/160 |
| 2010 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 30/106 |
| 2009 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 41/152 |
| 2009 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 23/93 |
| 2008 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 28/144 |
| 2008 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 16/83 |
| 2007 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 39/138 |
| 2007 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 25/81 |
| 2006 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 38/140 |
| 2006 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 25/76 |
| 2005 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 40/139 |
| 2005 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 26/72 |
| 2004 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 32/133 |
| 2004 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 23/71 |
| 2003 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 29/132 |
| 2003 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 16/72 |
| 2002 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 37/131 |
| 2002 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 27/74 |
| 2001 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | — | — | — |
| 2001 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | — | — | — |